Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 45Observational 2

Sponsor

Cancer Type

Plasma cell 2Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Multiple Myeloma 2Myelodysplastic Syndromes 1Metabolic Diseases 1Lymphoma 1Immunologic Deficiency Syndromes 1Anemia, Aplastic 1

Interventions

Blood Specimen Collection 123Surveys and Questionnaires 82Observation 49Radiotherapy 40Surgical Procedures, Operative 34Drug Therapy 34Biopsy 31Specimen Handling 28Data Collection 27Watchful Waiting 20Interviews as Topic 20Magnetic Resonance Imaging 18Immune Checkpoint Inhibitors 17Liquid Biopsy 16Magnetic Resonance Spectroscopy 15Immunotherapy 15Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Neoadjuvant Therapy 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Observational × Melphalan × Clear all
NCT03016806 2025-10-10

Umbilical Cord Blood Transplantation From Unrelated Donors

University of Rochester

Recruiting
30 enrolled
Classical hematologyLymphoidMyeloidPlasma cell

Anemia, Aplastic, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Multiple Myeloma, Myelodysplastic Syndromes

NCT06245629 2024-11-29

Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Uppsala University

Recruiting
100 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡